Search Results - Miklos Pless
- Showing 1 - 11 results of 11
-
1
Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK) by Benjamin Kasenda, Miklos Pless, Beat Thürlimann, Stefanie Hayoz, Annina Lea Schenker, Christoph Kopp, Sämi Schär, Roger von Moos
Published in BMJ Open (2023-04-01)Get full text
Article -
2
Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice by Richard Cathomas, Julian Schardt, Miklos Pless, Anna Llado, Nicolas Mach, Christian Riklin, Jenny Haefeli, Simon Fear, Frank Stenner
Published in Swiss Medical Weekly (2020-05-01)Get full text
Article -
3
Smartphone-Based Psychotherapeutic Interventions in Blended Care of Cancer Survivors: Nested Randomized Clinical Trial by Gunther Meinlschmidt, Astrid Grossert, Cornelia Meffert, Noa Roemmel, Viviane Hess, Christoph Rochlitz, Miklos Pless, Sabina Hunziker, Brigitta Wössmer, Ulfried Geuter, Rainer Schaefert
Published in JMIR Cancer (2023-08-01)Get full text
Article -
4
Estimating the indirect costs associated with adenocarcinoma or squamous cell carcinoma of the oesophagus in Switzerland: evidence from a cross-sectional survey by Matthias Schwenkglenks, Arjun Bhadhuri, Alexander Siebenhüner, Paola Salari, Miklos Pless, Andreas Wicki, Thibaud Koessler, Sandro T Stoffel, Dieter Koeberle, Letizia Deantonio, Tim Kahl, César Oniangue-Ndza
Published in BMJ Open (2025-02-01)Get full text
Article -
5
Effect of combined therapies including nutrition and physical exercise in advanced cancer patients: A pooled analysis by Lena J. Storck, Lena J. Storck, Alexandra Uster, Lucia Gafner, Maya Ruehlin, Sabine Gaeumann, David Gisi, Martina Schmocker, Peter J. Meffert, Reinhard Imoberdorf, Miklos Pless, Peter E. Ballmer
Published in Frontiers in Nutrition (2023-03-01)Get full text
Article -
6
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a... by Takaaki Tokito, Oleksii Kolesnik, Jens Sørensen, Mehmet Artac, Martín Lázaro Quintela, Jong-Seok Lee, Maen Hussein, Miklos Pless, Luis Paz-Ares, Lance Leopold, Jeannie Daniel, Mihaela Munteanu, Ayman Samkari, Lu Xu, Charles Butts
Published in BMC Cancer (2024-07-01)Get full text
Article -
7
Group-based body psychotherapy improves appreciation of body awareness in post-treatment cancer patients: A non-randomized clinical trial by Astrid Grossert, Astrid Grossert, Astrid Grossert, Astrid Grossert, Cornelia Meffert, Viviane Hess, Viviane Hess, Christoph Rochlitz, Christoph Rochlitz, Miklos Pless, Sabina Hunziker, Sabina Hunziker, Brigitta Wössmer, Brigitta Wössmer, Ulfried Geuter, Gunther Meinlschmidt, Gunther Meinlschmidt, Gunther Meinlschmidt, Gunther Meinlschmidt, Gunther Meinlschmidt, Rainer Schaefert, Rainer Schaefert
Published in Frontiers in Psychology (2023-04-01)Get full text
Article -
8
607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in... by Li Zhang, Goetz Kloecker, Christian Rolfo, Wallace Akerley, Miklos Pless, Lubos Petruzelka, Zoran Andric, Joachim Aerts, Libor Havel, Jeffrey Ward, Richard Greil, David E Gerber, Janusz Milanowski, Angelo Delmonte, Sujith Kalmadi, Rodryg Ramlau, Rupesh Kotecha, Corey Langer, Ticiana A Leal, Manuel Cobo Dols, Jaromír Roubec, Thierry Berghmans, Rajiv Panikkar, Michael Eaton, Mussawar Iqbal
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
9
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with s... by Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt, Alfred Zippelius
Published in Journal for ImmunoTherapy of Cancer (2019-02-01)Get full text
Article -
10
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy by Dominic Schmid, Bettina Sobottka, Massimiliano Manzo, Marta Trüb, Katharina Leonards, Petra Herzig, Oluwaseun Rume-Abiola Oyewole, Philip Jermann, Stefanie Hayoz, Spasenija Savic Prince, Giulia Tochtermann, Marina Natoli, Miklos Pless, Adrienne Bettini, Martin Früh, Laetitia A. Mauti, Christian Britschgi, Solange Peters, Michael Mark, Adrian F. Ochsenbein, Wolf-Dieter Janthur, Christine Waibel, Nicolas Mach, Patrizia Froesch, Martin Buess, Pierre Bohanes, Michel Gonzalez, Ilaria Alborelli, Sacha I. Rothschild, Viktor Hendrik Koelzer, Alfred Zippelius
Published in Nature Communications (2025-09-01)Get full text
Article -
11
Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment—A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01... by Sabine Raimann, MD, Sämi Schär, PhD, Stefanie Hayoz, PhD, Matthias Guckenberger, MD, Tobias Finazzi, MD, PhD, Isabelle Opitz, MD, Sabine Schmid, MD, Michael Mark, MD, Alfredo Addeo, MD, Laetitia A. Mauti, MD, PhD, Daniel C. Betticher, MD, Hans-Beat Ris, MD, Roger Stupp, MD, Alessandra Curioni-Fontecedro, MD, Solange Peters, MD, PhD, Martin Früh, MD, Sacha I. Rothschild, MD, PhD, Miklos Pless, MD, David König, MD
Published in JTO Clinical and Research Reports (2025-06-01)Get full text
Article
